- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment - Abstract
November 15, 2011
Prostate cancer detection on dynamic contrast-enhanced MRI: Computer-aided diagnosis versus single perfusion parameter maps - Abstract
November 15, 2011
Cancer screening: Curative or harmful? : An ethical dilemma facing the physician - Abstract
November 14, 2011
Intravenous therapies for castration-resistant prostate cancer: Toxicities and adverse events - Abstract
November 14, 2011
Does urological cancer mortality increase with low population density of physicians? - Abstract
November 14, 2011
Improving positioning in high-dose radiotherapy for prostate cancer: Safety and visibility of frequently used gold fiducial markers - Abstract
November 14, 2011
Outcomes in patients with Gleason score 8-10 prostate cancer: Relation to preoperative PSA level - Abstract
November 14, 2011
Immunotherapy in the treatment of advanced prostate cancer - Abstract
November 14, 2011
Screening for prostate cancer 2011: The current evidence and guidelines controversy - Abstract
November 14, 2011
Active surveillance as a treatment option for prostate cancer - Abstract
November 14, 2011
How can early detection programs become a men's health topic? : Survey of urology practices - Abstract
November 11, 2011
Modern detection of prostate cancer's bone metastasis: Is the bone scan era over? - Abstract
November 11, 2011
RANKL-targeted therapies: The next frontier in the treatment of male osteoporosis - Abstract
November 11, 2011
Evaluation of the use of digital images for a national prostate core external quality assurance scheme - Abstract
November 11, 2011
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion - Abstract
November 11, 2011
Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer - Abstract
November 11, 2011
Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer - Abstract
November 11, 2011